The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
Open accessAbstract
Several strategies have been pursued to increase the extent of exon 7 inclusion during splicing of SMN2 (survival of motor neuron 2) transcripts, for eventual therapeutic use in spinal muscular atrophy (SMA), a genetic neuromuscular disease. Antisense oligonucleotides (ASOs) that target an exon or its flanking splice sites usually promote exon skipping. Here we systematically tested a large number of ASOs with a 2'-O-methoxy-ethyl ribose (MOE) backbone that hybridize to different positions of SMN2 exon 7, and identified several that promote greater exon inclusion, others that promote exon skipping, and still others with complex effects on the accumulation of the two alternatively spliced products. This approach provides positional information about presumptive exonic elements or secondary structures with positive or negative effects on exon inclusion. The ASOs are effective not only in cell-free splicing assays, but also when transfected into cultured cells, where they affect splicing of endogenous SMN transcripts. The ASOs that promote exon 7 inclusion increase full-length SMN protein levels, demonstrating that they do not interfere with mRNA export or translation, despite hybridizing to an exon. Some of the ASOs we identified are sufficiently active to proceed with experiments in SMA mouse models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Morgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
An extensive network of coupling among gene expression machines
Maniatis, T., & Reed, R. (2002) · Nature · doi:10.1038/416499a · Cited by 1,146
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Cartegni, L., & Krainer, A. R. (2002) · Nature Genetics · doi:10.1038/ng854 · Cited by 730
Self-citationMonani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
The survival motor neuron protein in spinal muscular atrophy
Coovert, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1205 · Cited by 714
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany)
Munsat, T. L., & Davies, K. E. (1992) · Neuromuscular Disorders · doi:10.1016/s0960-8966(06)80015-5 · Cited by 666
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Scaffidi, P., & Misteli, T. (2005) · Nature Medicine · doi:10.1038/nm1204 · Cited by 553
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
Kashima, T., & Manley, J. L. (2003) · Nature Genetics · doi:10.1038/ng1207 · Cited by 546
Essential Role for the SMN Complex in the Specificity of snRNP Assembly
Pellizzoni, L., Yong, J., & Dreyfuss, G. (2002) · Science · doi:10.1126/science.1074962 · Cited by 545
SMN oligomerization defect correlates with spinal muscular atrophy severity
Lorson, C. L., Strasswimmer, J., Yao, J.-M., Baleja, J. D., Hahnen, E., Wirth, B., Le, T., Burghes, A. H. M., & Androphy, E. J. (1998) · Nature Genetics · doi:10.1038/ng0598-63 · Cited by 500
Alter, J., Lou, F., Rabinowitz, A., Yin, H., Rosenfeld, J., Wilton, S. D., Partridge, T. A., & Lu, Q. L. (2006) · Nature Medicine · doi:10.1038/nm1345 · Cited by 494
Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1333-1346.2006 · Cited by 454
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
Lorson, C. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.2.259 · Cited by 435
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski, Z., & Kole, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8673 · Cited by 426
Lu, Q. L., Rabinowitz, A., Chen, Y. C., Yokota, T., Yin, H., Alter, J., Jadoon, A., Bou-Gharios, G., & Partridge, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406700102 · Cited by 402
Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., & Bennett, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11994 · Cited by 371
Self-citationMolecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2
Mailman, M. D., Heinz, J. W., Papp, A. C., Snyder, P. J., Sedra, M. S., Wirth, B., Burghes, A. H. M., & Prior, T. W. (2002) · Genetics in Medicine · doi:10.1097/00125817-200201000-00004 · Cited by 364
Hofmann, Y., Lorson, C. L., Stamm, S., Androphy, E. J., & Wirth, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160181697 · Cited by 314
A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs
Meister, G., Bühler, D., Pillai, R., Lottspeich, F., & Fischer, U. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-945 · Cited by 307
Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2
Cartegni, L., Hastings, M. L., Calarco, J. A., de Stanchina, E., & Krainer, A. R. (2006) · The American Journal of Human Genetics · doi:10.1086/498853 · Cited by 306
Self-citationCorrection of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
Self-citationGubitz, A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.022 · Cited by 274
Skordis, L. A., Dunckley, M. G., Yue, B., Eperon, I. C., & Muntoni, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633863100 · Cited by 274
International SMA consortium meeting
Munsat, T. L. (1992) · Medical Entomology and Zoology · Cited by 243
Repair of thalassemic human β-globin mRNA in mammalian cells by antisense oligonucleotides
Sierakowska, H., Sambade, M. J., Agrawal, S., & Kole, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12840 · Cited by 236
Promoter usage and alternative splicing
Kornblihtt, A. R. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.04.014 · Cited by 236
Advances in Duchenne muscular dystrophy gene therapy
van Deutekom, J. C. T., & van Ommen, G.-J. B. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1180 · Cited by 221
McKay, R. A., Miraglia, L. J., Cummins, L. L., Owens, S. R., Sasmor, H., & Dean, N. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1715 · Cited by 220
Antisense Drug Technology: Principles, Strategies, and Applications
Szymkowski, D. E. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02123-7 · Cited by 218
Survival Motor-Neuron Gene Transcript Analysis in Muscles from Spinal Muscular-Atrophy Patients
Gennarelli, M., Lucarelli, M., Capon, F., Pizzuti, A., Merlini, L., Angelini, C., Novelli, G., & Dallapiccola, B. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2135 · Cited by 199
Lim, S. R., & Hertel, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107632200 · Cited by 159
Survival motor neuron protein facilitates assembly of stress granules
Hua, Y., & Zhou, J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.07.010 · Cited by 151
Self-citationSingh, N. N., Androphy, E. J., & Singh, R. N. (2004) · RNA · doi:10.1261/rna.7580704 · Cited by 140
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.067 · Cited by 117
Preparation of Hela Cell Nuclear and Cytosolic S100 Extracts for In Vitro Splicing
Mayeda, A., & Krainer, A. R. (2003) · Humana Press eBooks · doi:10.1385/1-59259-676-2:309 · Cited by 112
Self-citationIdentification of a Cis-acting Element for the Regulation ofSMN Exon 7 Splicing
Miyajima, H., Miyaso, H., Okumura, M., Kurisu, J., & Imaizumi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200851200 · Cited by 101
Therapeutics development for spinal muscular atrophy
Sumner, C. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.010 · Cited by 97
Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs
Madocsai, C., Lim, S. R., Geib, T., Lam, B. J., & Hertel, K. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.022 · Cited by 92
Stimulating Full-Length SMN2 Expression by Delivering Bifunctional RNAs via a Viral Vector
Baughan, T. D., Shababi, M., Coady, T. H., Dickson, A., Tullis, G. E., & Lorson, C. L. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.012 · Cited by 75
Vickers, T. A., Zhang, H., Graham, M. J., Lemonidis, K. M., Zhao, C., & Dean, N. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3652 · Cited by 54
Self-citationAntisense-mediated redirection of mRNA splicing
Vacek, M. M., Sazani, P., & Kole, R. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3042-7 · Cited by 54
The Regulation and Regulatory Activities of Alternative Splicing of the SMN Gene
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.v14.i4.30 · Cited by 51
Wilton, S. D., & Fletcher, S. (2005) · Current Gene Therapy · doi:10.2174/156652305774329249 · Cited by 51
Can a ‘patch’ in a skipped exon make the pre-mRNA splicing machine run better?
Buratti, E., Baralle, F. E., & Pagani, F. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00072-8 · Cited by 16
Eperon, I. C., & Francesco Muntoni, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00068-6 · Cited by 6
Cited by
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Self-citationRNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Self-citationSplicing in disease: disruption of the splicing code and the decoding machinery
Wang, G.-S., & Cooper, T. A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2164 · Cited by 1,050
Finkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31408-8 · Cited by 1,019
Self-citationAntisense technology: an overview and prospectus
Crooke, S. T., Baker, B. F., Crooke, R. M., & Liang, X.-H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00162-z · Cited by 775
Self-citation
Metadata
- Authors
- Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F., & Krainer, A. R.
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-03-13
- Volume
- 5
- Issue
- 4
- Pages
- e73
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- OpenAlex
- W2025722577
- Cited by
- 340
- References
- 52
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.